Triptorelin cas 57773-63-4

Triptorelin is a synthetic gonadotropin-releasing hormone (GnRH) peptide agonist that binds to the GnRH receptor. It inhibits the growth of DU145, LNCaP, and PC3 prostate and OVCAR-3 ovarian cancer cells.

Related Prodcuts:

Abaloparatide; Tetracosactide; Thymalfasin; Thymosin alpha 1; Thymosin beta 4; Triptorelin Acetate; Vapreotide; Vasopressin; Ziconotide Acetate; Antide; Protirelin; Teduglutide; Eledoisin; Aviptadil; Teriparatide acetate

1. Nederpelt, I., Georgi, V., Schiele, F., et al. Characterization of 12 GnRH peptide agonists - a kinetic perspective. Br. J. Pharmacol. 173(1), 128-141 (2016).

2. Varamini, P., Rafiee, A., Giddam, A.K., et al. Development of new gonadotropin-releasing hormone-modified dendrimer platforms with direct antiproliferative and gonadotropin releasing activity. J. Med. Chem. 60(20), 8309-8320 (2017).